ImmunoBiome Inc.
PrivateLast Round
Series B
Jan 1, 2022
Total Funding Raised
$23.81M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
ImmunoBiome Inc. is a biotechnology company that develops microbiome-targeted therapeutics and live biotherapeutic products (LBPs) for incurable diseases such as cancer, autoimmune disorders, and autism spectrum disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Infrastructure
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ImmunoBiome Inc. Comparables
Compare ImmunoBiome Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Enterobiome Inc. | 87% | |
| Exeliom Biosciences | 81% | |
| PharmaBiome | 80% | |
ImmunoBiome Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jan 1, 2022 | ||||
| Series A | Sep 1, 2020 | ||||
| Pre Seed | Dec 1, 2019 | ||||
| Seed | Jul 1, 2019 |
ImmunoBiome Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Korea Investment Partners | Series B, Series A |
| Company K Partners | Series B |
| Brain Asset Management Co.,Ltd. | Series B |
| Korea Investment & Securities | Series B |
| Union Investment Partners | Series B |
| KTB Investment Group | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 3, 2026
Open roles increased to 398, 1895% of headcount.
- Mar 4, 2026
Monthly visitors increased 61% MoM.
ImmunoBiome Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about ImmunoBiome Inc.'s valuation, stock price, and market status.